Title: Study of Effect of L-Arginine in IUGR Cases with Its Fetal Outcome
Authors: Dr Ritu Kumari, Dr Anjana Sinha
DOI: https://dx.doi.org/10.18535/jmscr/v8i2.133
Abstract
IUGR is a major cause of infant mortality & morbidity worldwide. The current management of IUGR being empirical & aimed of selecting a safe time for delivery. Acknowledging, the beneficial effect of L-arginine on endothelial vasculature by producing NO through L-Arginine/No Pathway by sterocospeicific enzyme NO SYNTHETASE, & arginine deficiency may play an important role in causation of IUGR. Starting from 3rd wk of therapy, the umbilical artery pulsatility index were significantly lower in l-arginine then in placebo group. Treatment with L-arginine caused significant increase of middle cerebral artery pulsatility indices & cerebro placental ratio values. The present study showed that neonates delivered in L-arginine group had higher Apgar score. Supplementary t/t with oral L-arginine seems to be promising in improving fetal well bring & neonatal outcome as well as in prolonging pregnancy complicated with preeclampsia.
References
- Divon MY, Hsu HW. Maternal and fetal blood flow velocity waveforms in intrauterine growth retardation. Clin Obstet Gynecol. 1992;35:156-171.
- Biswas R, Dasgupta A, Sinha RN, Chaudhri RN. An epidemiological study of low birth weight newborns in the district of puruliya, West Bengal, India 2008;52(2)65-71.
- Gluckman PD, Hanson MA. The consequences of being born small: an adaptive perspective. Horns Res. 2006;65:5-14.
- Mari G, Hanif F. Intrauterine growth restriction: how to manage and when to deliver. Clin Obstet Gynecol. 2007; 50:497-509.
- Sankaran S, Kyle PM. Aetiology and pathogenesis of IUGR. Best Pract Res Clin Obstet Gynaecol. 2009;23(6)765-777.